title: The design and synthesis of water-soluble analogues of CB30865, a quinazolin-4-one-based antitumor agent.
abstract: 4-[N-[7-Bromo-2-methyl-4-oxo-3,4-dihydroquinazolin-6-ylmethyl]-N-(prop-2-ynyl)amino]-N-(3-pyridylmethyl)benzamide (CB30865) is a quinazolin-4-one antitumor agent whose high growth-inhibitory activity (W1L2 IC(50) = 2.8 +/- 0.50 nM) is believed to have a folate-independent locus of action. In addition, CB30865 represents a class of compounds with unique biochemical characteristics such as a delayed, non-phase specific, cell-cycle arrest. The low aqueous solubility of CB30865 prompted a search for more water-soluble analogues for in vivo evaluation of this class of compounds. It was thought that aqueous solubility could be increased by the introduction of amino functionalities at the 2-position of the quinazolin-4-one ring. A variety of compounds (5a-j, 31a-c, 32, and 33) were synthesized in a linear fashion starting from 3-chloro-4-methylaniline. Most of these compounds (e.g., 5a, 5b, 5g) were significantly more water-soluble than CB30865 (636 microM for 5a at pH 6 and 992 microM for 5g at pH 6). In addition, some of them were up to 6-fold more cytotoxic than CB30865 (e.g., for 5a, W1L2 IC(50) = 0.49 +/- 0.24 nM) and retained its novel biochemical characteristics.
authors.affiliation: Cancer Research U.K. Centre for Cancer Therapeutics at The Institute of Cancer Research, Chemistry Department, Cancer Research U.K. Laboratory, 15 Cotswold Road, Sutton, Surrey SM2 5NG, U.K. vassilio@icr.ac.uk
authors.forename: V
authors.initials: V
authors.lastname: Bavetsias
authors.forename: L A
authors.initials: LA
authors.lastname: Skelton
authors.forename: F
authors.initials: F
authors.lastname: Yafai
authors.forename: F
authors.initials: F
authors.lastname: Mitchell
authors.forename: S C
authors.initials: SC
authors.lastname: Wilson
authors.forename: B
authors.initials: B
authors.lastname: Allan
authors.forename: A L
authors.initials: AL
authors.lastname: Jackman
mesh_terms: D000970:Antineoplastic Agents / Q000138:chemical synthesis* / Q000737:chemistry / Q000494:pharmacology; D002455:Cell Division / Q000187:drug effects; D004354:Drug Screening Assays, Antitumor; D006801:Humans; D020128:Inhibitory Concentration 50; D011799:Quinazolines / Q000138:chemical synthesis* / Q000737:chemistry / Q000494:pharmacology; D012995:Solubility; D013329:Structure-Activity Relationship; D014407:Tumor Cells, Cultured
chemical_list: D000970:Antineoplastic Agents; C403613:CB 30865; D011799:Quinazolines